Robot-Assisted surgery trial aims to ease swelling in head and neck lymphedema
NCT ID NCT07311876
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will test the Symani Surgical System, a robotic device designed to help surgeons perform delicate microsurgery on lymph vessels in the head and neck. The goal is to see if the robot can safely and effectively reconnect lymph channels to reduce swelling (lymphedema) in 30 adults. Participants will be followed for 30 days after surgery to check for complications and improvements in fluid drainage.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Symani Surgical System (a robotic device for microsurgery)
What this could lead to
If successful, this could provide a safer, more precise surgical option for treating head and neck lymphedema, potentially improving drainage and reducing swelling.
What could go wrong
This is a small, early-stage study (30 people) focused on device safety and feasibility, not a proven treatment. The procedure carries surgical risks like infection or device-related complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHEDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.